The aim of the study is to assess the safety and efficacy of a Paclitaxel-eluting PTCA-balloon in combination with bare-metal stenting for treatment of chronic total occlusions in native coronary arteries with reference diameters between 2.5 mm and 4.0 mm.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
48
paclitaxel eluting PTCA balloon catheter after bare-metal stenting of chronic total occlusion in a native coronary artery
paclitaxel-eluting Taxus stents (Boston Scientific) in chronic total occlusion in native coronary arteries
Klinikum Darmstadt
Darmstadt, Germany
University of Ulm
Ulm, Germany
Late loss
Time frame: 6 months
percent diameter stenosis
Time frame: 6 months
binary angiographic restenosis rate
Time frame: 6 months
late loss index
Time frame: 6 months
Target lumen revascularization
Time frame: 30 days, 6, 12, 24 months
target vessel revascularization
Time frame: 30 days, 6, 12, 24 months
major adverse cardiac events
Time frame: 30 days, 6, 12, 24 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.